Maintained superiority of chronotherapeutics vs. exercise in a 20-week randomized follow-up trial in major depression
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To investigate the long-term antidepressant effect of a chronotherapeutic intervention. METHOD: In this randomized controlled trial 75 patients with major depression were allocated to fixed duloxetine and either a chronotherapeutic intervention (wake group) with three initial wake therapies, daily bright light therapy, and sleep time stabilization or to a group using daily exercise. Patients were followed 29 weeks. We report the last 20 weeks, a follow-up phase, where medication could be altered. Patients were assessed every 4 weeks. Remission rates were primary outcome. RESULTS: Patients in the wake group had a statistically significant higher remission rate of 61.9% vs. 37.9% in the exercise group at week 29 (OR = 2.6, CL = 1.3-5.6, P = 0.01). This indicated continued improvement compared with the 9 weeks of treatment response (44.8% vs. 23.4%) with maintenance of the large difference between groups. HAM-D17 endpoint scores were statistically lower in the wake group with endpoint scores of 7.5 (SE = 0.9) vs. 10.1 (SE = 0.9) in the exercise group (difference 2.7, CL = 0.5-4.8, P = 0.02). CONCLUSION: In this clinical study patients continued to improve in the follow-up phase and obtained very high remission rates. This is the first study to show adjunct short-term wake therapy and long-term bright light therapy as an effective and feasible method to attain and maintain remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub6 · Cited by 1,834
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705 · cited 1×
“6) [21–70] 48.”
Self-citationBech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015 · cited 1×
“6) [21–70] 48.”
Self-citationBech, P., Rasmussen, N.-A., Olsen, L. R., Noerholm, V., & Abildgaard, W. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00309-8 · Cited by 975 · cited 1×
“6) [21–70] 48.”
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
Thabane, L., Mbuagbaw, L., Zhang, S., Samaan, Z., Marcucci, M., Ye, C., Thabane, M., Giangregorio, L., Dennis, B., Kosa, D., et al. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-92 · Cited by 893 · cited 1×
“6) [21–70] 48.”
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
McIntyre, R. S., Filteau, M.-J., Martin, L., Patry, S., Carvalho, A., Cha, D. S., Barakat, M., & Miguelez, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.043 · Cited by 421 · cited 1×
“0) [0–40] 6.”
Krogh, J., Nordentoft, M., Sterne, J. A. C., & Lawlor, D. A. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04913blu · Cited by 326
Chronotherapeutics (light and wake therapy) in affective disorders
WIRZ-JUSTICE, A., BENEDETTI, F., BERGER, M., LAM, R. W., MARTINY, K., TERMAN, M., & WU, J. C. (2005) · Psychological Medicine · doi:10.1017/s003329170500437x · Cited by 291 · cited 1×
“9) [10–66] 32.”
Self-citationThe SCL‐90 and SCL‐90R versions validated by item response models in a Danish community sample
Olsen, L. R., Mortensen, E. L., & Bech, P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00399.x · Cited by 285
Self-citationWu, J. C., Kelsoe, J. R., Schachat, C., Bunney, B. G., DeModena, A., Golshan, S., Gillin, J. C., Potkin, S. G., & Bunney, W. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.018 · Cited by 263 · cited 1×
“9) [10–66] 32.”
Bech, P. (2012) · doi:10.1002/9781118511800 · Cited by 243
Self-citationPartial remission, residual symptoms, and relapse in depression
Paykel, E. S. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/espaykel · Cited by 194
Benedetti, F., Riccaboni, R., Locatelli, C., Poletti, S., Dallaspezia, S., & Colombo, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08455 · Cited by 116 · cited 1×
“6) [21–70] 48.”
Controlled trial of bright light and negative air ions for chronic depression
GOEL, N., TERMAN, M., SU TERMAN, J., MACCHI, M. M., & STEWART, J. W. (2005) · Psychological Medicine · doi:10.1017/s0033291705005027 · Cited by 115 · cited 1×
“9) [10–66] 32.”
Miskowiak, K. W., Vinberg, M., Christensen, E. M., Bukh, J. D., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.335 · Cited by 104
Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy
Wirz-Justice, A., Benedetti, F., & Terman, M. (2013) · doi:10.1159/isbn.978-3-318-02091-5 · Cited by 99
What was learned: studies by the consortium for research in ECT(CORE) 1997–2011
Fink, M. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12251 · Cited by 97
Martiny, K., Refsgaard, E., Lund, V., Lunde, M., Sørensen, L., Thougaard, B., Lindberg, L., & Bech, P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07625 · Cited by 87 · cited 1×
“6) [21–70] 48.”
Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-60 · Cited by 57 · cited 1×
“6) [21–70] 48.”
Benedetti, F., Calabrese, G., Bernasconi, A., Cadioli, M., Colombo, C., Dallaspezia, S., Falini, A., Radaelli, D., Scotti, G., & Smeraldi, E. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.08.004 · Cited by 53 · cited 1×
“9) [10–66] 32.”
Martiny, K., Refsgaard, E., Lund, V., Lunde, M., Sørensen, L., Thougaard, B., Lindberg, L., & Bech, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067264 · Cited by 43 · cited 1×
“6) [21–70] 48.”
Self-citationThe impact of the SCL-90 on the validity of the DSM-IV neurotic or stress-related disorders
Bech, P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00382.x · Cited by 15
Self-citation
Research works printed but not linked: 28
- Angst, 1995, Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985, Schweiz Arch Neurol Psychiatr, 146, 17
- Mignon, 2009, Clinical management of major depressive disorder, CNS Spectr, 14, 3, 10.1017/S1092852900003837 · DOI
- Connolly, 2010, If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies, Drugs, 71, 43, 10.2165/11587620-000000000-00000 · DOI · Paper page
- Rush, 2004, One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies, Biol Psychiatry, 56, 46, 10.1016/j.biopsych.2004.04.005 · DOI
- Sokero, 2005, Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder, Br J Psychiatry, 186, 314, 10.1192/bjp.186.4.314 · DOI · Paper page
- Kennedy, 2005, The impact of residual symptoms on outcome of major depression, Curr Psychiatry Rep, 7, 441, 10.1007/s11920-005-0065-9 · DOI
- Malhi, 2013, Chronobiology of mood disorders, Acta Psychiatr Scand Suppl, 444, 2, 10.1111/acps.12173 · DOI · Paper page
- Steinberg, 2014, Johann Christian August Heinroth on sleep deprivation as a therapeutic option for depressive disorders, Sleep Med, 15, 1159, 10.1016/j.sleep.2014.03.027 · DOI
- Wu, 1992, Effect of sleep deprivation on brain metabolism of depressed patients, Am J Psychiatry, 149, 538, 10.1176/ajp.149.4.538 · DOI · Paper page
- Dallaspezia, 2011, Chronobiological therapy for mood disorders, Expert Rev Neurother, 11, 961, 10.1586/ern.11.61 · DOI · Paper page
- Martiny, 2005, Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales, Acta Psychiatr Scand, 112, 117, 10.1111/j.1600-0447.2005.00574.x · DOI · Paper page
- Martiny, 2009, High cortisol awakening response is associated with an impairment of the effect of bright light therapy, Acta Psychiatr Scand, 120, 196, 10.1111/j.1600-0447.2009.01359.x · DOI
- Krogh, 2012, DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial, PLoS ONE, 7, e48316, 10.1371/journal.pone.0048316 · DOI · Paper page
- EMEA, 1997, The European Agency for the evaluation of medicinal products. Note for guidance on Good Clinical Practice (CPMP/ICH/135/95)
- Terman, 2010, Principles and practice of sleep medicine, 1682
- Sheehan, 1998, The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview, J Clin Psychiatry, 59, 22
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- O'Sullivan, 1997, Sensitivity of the six-item Hamilton Depression Rating Scale, Acta Psychiatr Scand, 95, 379, 10.1111/j.1600-0447.1997.tb09649.x · DOI · Paper page
- Bech, 2002, The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure, Acta Psychiatr Scand, 106, 252, 10.1034/j.1600-0447.2002.01404.x · DOI · Paper page
- Bech, 2004, Measuring the dimensions of psychological general well-being by the WHO-5, QoL Newsletter, 32, 15
- Borg, 1982, Psychophysical bases of perceived exertion, Med Sci Sports Exerc, 14, 377, 10.1249/00005768-198205000-00012 · DOI · Paper page
- Fekadu, 2009, A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method, J Clin Psychiatry, 70, 177, 10.4088/JCP.08m04309 · DOI · Paper page
- National Research Council (US) Panel on Handling Missing Data in Clinical Trials, 2010, The prevention and treatment of missing data in clinical trials
- Hedges, 1985, Statistical methods for meta-analysis, 78
- Ostergaard, 2014, Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC), J Affect Disord, 163, 18, 10.1016/j.jad.2014.03.049 · DOI
- Bech, 2014, Psychometric analysis of the Melancholia Scale in trials with non-pharmacological augmentation of patients with therapy-resistant depression, Acta Neuropsychiatr, 26, 155, 10.1017/neu.2013.51 · DOI
- Machado, 2006, Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials, Curr Med Res Opin, 22, 1825, 10.1185/030079906X132415 · DOI · Paper page
- Oldham, 2014, Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system, Chronobiol Int, 31, 305, 10.3109/07420528.2013.833935 · DOI · Paper page
Cited by
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337
“Similarly, medication paired with chronotherapeutic techniques (LT, sleep deprivation, and sleep time stabilization) led to superior remission rates in nonseasonal MDD compared to medication combined with exercise at both 9-week and 29-week follow-up.(24,27) In summary, the updated evidence continues to support LT as…”
BackgroundSleep deprivation as treatment for depression: systematic review and meta-analysis
Ioannou, M., Wartenberg, C., Greenbrook, J. T. V., Larson, T., Magnusson, K., Schmitz, L., Sjögren, P., Stadig, I., Szabó, Z., & Steingrimsson, S. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13253 · Cited by 75
Chronotherapy for the rapid treatment of depression: a meta-analysis
Humpston, C., Benedetti, F., Serfaty, M., Markham, S., Hodsoll, J., Young, A. H., & Veale, D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.078 · Cited by 45
(2018) · doi:10.1024/1422-4917/a000603 · Cited by 33
Wake and light therapy for moderate-to-severe depression – a randomized controlled trial
Kragh, M., Martiny, K., Videbech, P., Møller, D. N., Wihlborg, C. S., Lindhardt, T., & Larsen, E. R. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12741 · Cited by 25
“6) [17] 13 (12) [12] Zopiclone mean mg (SD) [n] 7 (0) [6] 7 (0) [6] Used sleeping agents in the study period %[n] 67 [20] 56 [17]”
Background
Metadata
- Authors
- Martiny, K., Refsgaard, E., Lund, V., Lunde, M., Thougaard, B., Lindberg, L., & Bech, P.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2015-02-17
- Volume
- 131
- Issue
- 6
- Pages
- 446-457
- ISSN
- 0001-690X (ISSN-L)
- OpenAlex
- W2097788410
- Cited by
- 37
- References
- 23
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 196 d)
- Funders
- Eli Lilly and Company
- ; Frederiksborg General Hospital, Hillerød, Denmark
- Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark
- The Olga Bryde Nielsen Foundation, Hillerød, Denmark
- The Region 3 Foundation, Copenhagen, Denmark
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.